Stock Market Reviews

HRTX (Heron Therapeutics, Inc.) News

Get the latest news, insights, and market updates on HRTX (Heron Therapeutics, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Heron Therapeutics Completes Capital Restructuring
  Heron Therapeutics (HRTX) said Friday it has completed its capital restructuring to boost financial
  Aug 8, 2025 - $HRTX
• Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress
  Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three and six months ended June 30, 2025 and recent corporate updates.
  Aug 8, 2025 - $HRTX
• Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
  CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth.
  Aug 8, 2025 - $HRTX
• Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025
  Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, August 11, 2025, at 4:30 p.m. ET to report second quarter 2025 financial results and discuss recent business highlights.
  Jul 29, 2025 - $HRTX
• With 60% institutional ownership, Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst the big guns
  Key Insights Institutions' substantial holdings in Heron Therapeutics implies that they have significant influence over...
  Jun 30, 2025 - $HRTX
• Results: Heron Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
  Last week, you might have seen that Heron Therapeutics, Inc. ( NASDAQ:HRTX ) released its first-quarter result to the...
  May 9, 2025 - $HRTX